Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,298,789
  • Shares Outstanding, K 70,129
  • Annual Sales, $ 0 K
  • Annual Income, $ -209,340 K
  • 60-Month Beta 2.88
  • Price/Sales 5.87
  • Price/Cash Flow N/A
  • Price/Book 22.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.68
  • Number of Estimates 3
  • High Estimate 0.73
  • Low Estimate 0.64
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +173.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.22 +7.55%
on 12/03/19
20.21 -8.36%
on 11/20/19
-0.68 (-3.54%)
since 11/13/19
3-Month
15.50 +19.48%
on 11/05/19
23.91 -22.54%
on 09/25/19
-1.68 (-8.32%)
since 09/13/19
52-Week
8.32 +122.60%
on 01/04/19
23.91 -22.54%
on 09/25/19
+8.54 (+85.57%)
since 12/13/18

Most Recent Stories

More News
Top Ranked Momentum Stocks to Buy for December 3rd

Top Ranked Momentum Stocks to Buy for December 3rd

UFAB : 3.66 (-0.27%)
OTIC : 2.49 (+0.81%)
IRWD : 12.79 (+1.35%)
CHRS : 18.52 (+1.48%)
Top Ranked Momentum Stocks to Buy for November 26th

Top Ranked Momentum Stocks to Buy for November 26th

HIBB : 26.45 (-2.60%)
CPRT : 88.62 (+0.16%)
CHRS : 18.52 (+1.48%)
AMKR : 12.79 (+0.39%)
Look for Shares of Coherus Bioscien to Potentially Pullback after Yesterday's 1.98% Rise

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $19.09 to a high of $19.66. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high...

CHRS : 18.52 (+1.48%)
Interesting CHRS Put And Call Options For January 2020

Investors in Coherus BioSciences Inc saw new options begin trading this week, for the January 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CHRS options...

CHRS : 18.52 (+1.48%)
Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline

Alkermes (ALKS) will acquire Rodin Therapeutics for an upfront cash payment of $100 million and up to $850 million in milestone payments.

CHRS : 18.52 (+1.48%)
ANIK : 53.15 (-0.65%)
ALKS : 20.87 (-1.79%)
GH : 75.90 (+4.65%)
Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences

Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS), today announced that senior management will present at two upcoming investor healthcare conferences.

CHRS : 18.52 (+1.48%)
The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and Celgene

The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and Celgene

ACAD : 44.34 (-0.40%)
CHRS : 18.52 (+1.48%)
CELG : 108.24 (+0.10%)
INCY : 91.51 (-1.44%)
4 Biotech Stocks That Could Keep Beating Wall Street

The biotechnology industry has lagged the broader market so far this year, but these four stocks have done pretty well and should continue to do so.

BMY : 63.82 (-0.19%)
LLY : 121.53 (-0.14%)
ACAD : 44.34 (-0.40%)
CHRS : 18.52 (+1.48%)
CELG : 108.24 (+0.10%)
BIIB : 296.83 (+1.01%)
INCY : 91.51 (-1.44%)
ADPT : 30.20 (-4.64%)
ALEC : 20.21 (+1.40%)
NGM : 18.67 (+2.02%)
TAK : 20.23 (-0.44%)
Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective November 7, 2019, the compensation committee of the Company's board of directors granted options to...

CHRS : 18.52 (+1.48%)
Coherus Bioscien has the Best Relative Performance in the Biotechnology Industry (CHRS , VNDA , ATRA , EPZM , RDUS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ATRA : 15.45 (-3.38%)
CHRS : 18.52 (+1.48%)
VNDA : 16.73 (-1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade CHRS with:

Business Summary

Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid...

See More

Key Turning Points

2nd Resistance Point 19.07
1st Resistance Point 18.79
Last Price 18.52
1st Support Level 18.17
2nd Support Level 17.83

See More

52-Week High 23.91
Last Price 18.52
Fibonacci 61.8% 17.95
Fibonacci 50% 16.11
Fibonacci 38.2% 14.28
52-Week Low 8.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar